 Connection
Michael Narkewicz to Liver Function Tests
This is a "connection" page, showing publications Michael Narkewicz has written about Liver Function Tests.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.639 |
|
|
|
-
Narkewicz MR, Dell Olio D, Karpen SJ, Murray KF, Schwarz K, Yazigi N, Zhang S, Belle SH, Squires RH. Pattern of diagnostic evaluation for the causes of pediatric acute liver failure: an opportunity for quality improvement. J Pediatr. 2009 Dec; 155(6):801-806.e1.
Score: 0.314
-
Woodruff SA, Sontag MK, Accurso FJ, Sokol RJ, Narkewicz MR. Prevalence of elevated liver enzymes in children with cystic fibrosis diagnosed by newborn screen. J Cyst Fibros. 2017 01; 16(1):139-145.
Score: 0.128
-
Kobak GE, MacKenzie T, Sokol RJ, Narkewicz MR. Interferon treatment for chronic hepatitis B: enhanced response in children 5 years old or younger. J Pediatr. 2004 Sep; 145(3):340-5.
Score: 0.056
-
Narkewicz MR, Sondheimer HM, Ziegler JW, Otanni Y, Lorts A, Shaffer EM, Horgan JG, Sokol RJ. Hepatic dysfunction following the Fontan procedure. J Pediatr Gastroenterol Nutr. 2003 Mar; 36(3):352-7.
Score: 0.050
-
Narkewicz MR. Markers of cystic fibrosis-associated liver disease. J Pediatr Gastroenterol Nutr. 2001 Apr; 32(4):421-2.
Score: 0.044
-
Mayer-Hamblett N, Kloster M, Ramsey BW, Narkewicz MR, Saiman L, Goss CH. Incidence and clinical significance of elevated liver function tests in cystic fibrosis clinical trials. Contemp Clin Trials. 2013 Mar; 34(2):232-8.
Score: 0.025
-
Narkewicz MR, Sokol RJ, Beckwith B, Sondheimer J, Silverman A. Liver involvement in Alpers disease. J Pediatr. 1991 Aug; 119(2):260-7.
Score: 0.023
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|